Understanding the Pulmonary Valve And Semilunar Valve Architecture
The pulmonary valve sits at the junction where the right ventricle meets the pulmonary artery. It is one of the two semilunar valves in the heart, the other being the aortic valve. I have spent enough time looking at echocardiograms and surgical specimens to say these structures are more clinically interesting than most textbooks make them out to be. The anatomy is straightforward on paper, but the devil is in the details. Semilunar refers to the crescent-shaped cusps that line both the pulmonary and aortic valves. When someone says "pulmonary valve" they mean the specific valve on the right side. When they say "semilunar valve" without qualification, they could mean either one. In clinical conversations, this ambiguity causes actual problems. I once had a resident confidently tell me a patient had a bicuspid semilunar valve without specifying which side. Turns out it was the aortic valve, not the pulmonary, which changed the entire surgical approach. The pulmonary valve typically has three cusps: anterior, left, and right. They are named by their position, not by the sides of the body like you might expect. The anterior cusp is the most consistently visible on standard echocardiographic views. This matters because when you are doing transesophageal echo, you are working with limited windows, and the naming convention directly affects how you communicate findings to surgeons.
How the Pulmonary Valve Actually Functions
During systole, the right ventricle contracts and pushes blood through the open pulmonary valve into the pulmonary artery. The valve opens to a diameter of roughly 2.5 centimeters in adults. During diastole, the valve closes as pressure in the pulmonary artery exceeds right ventricular pressure. The three semilunar cusps fold together like a pocket, creating a tight seal that prevents regurgitation. Here is something most people miss: the pulmonary valve is more variable in its geometry than the aortic valve. The aortic valve sits in a relatively fixed triangular position between the left ventricle and the ascending aorta. The pulmonary valve moves with the cardiac cycle. It shifts downward during systole as the right ventricle contracts. This movement is called the "annular plane displacement" and it can be up to 1 centimeter over a single heartbeat. If you are measuring the pulmonary valve annulus on a static image, you are probably wrong. I learned this the hard way. A few years ago I was reviewing a post-operative echo after a pulmonary valve replacement. The surgeon had implanted a bioprosthetic valve, and the echocardiographer was reporting a small paravalvular leak. I kept looking at it and could not find it on any view. Eventually I realized we were measuring during systole, when the annulus had descended and the prosthetic ring was sitting at a different level than it would at end-diastole. We repeated the measurement at the right point in the cycle and found nothing. That was a good reminder that timing matters as much as technique when you are working with semilunar valves.
Common Pathologies and What to Look For
Pulmonary valve stenosis is the most common pathological condition affecting this valve. It is usually congenital. The valve cusps become thickened and domed, restricting flow from the right ventricle. On echocardiography, you see a characteristic dome shape during systole. The peak velocity across the valve tells you the severity. A velocity greater than 3 meters per second indicates moderate stenosis. Greater than 4 meters per second is severe. Pulmonary regurgitation is actually more common than stenosis in adult practice. It frequently follows repair of tetralogy of Fallot. Surgeons have to divide the pulmonary valve annulus to relieve obstruction, and this disrupts the valve leaflets. The resulting regurgitation is usually mild to moderate immediately after surgery. Over time, the chronic volume load on the right ventricle can cause dilation and dysfunction. This is a slow process that takes years to develop. Regular follow-up imaging is essential. There is a counter-intuitive point here that beginners often miss. Mild pulmonary regurgitation in an asymptomatic patient is not necessarily an indication for intervention. The right ventricle tolerates chronic volume overload better than most clinicians expect. I have followed patients with significant pulmonary regurgitation for over a decade without intervention. The key is watching the right ventricular size and function on serial imaging. When the RV end-diastolic volume exceeds 160 milliliters per meter squared, that is when the conversation about reoperation becomes relevant. It is not a simple yes or no decision.
Intervention Options and Trade-offs
Percutaneous pulmonary valve implantation is now a well-established treatment for patients with dysfunctional right ventricular outflow tracts. The Edwards SAPIEN valve has been used in hundreds of cases through the Transcatheter Pulmonary Valve Replacement (TPVR) pathway. It was first approved in the United States in 2010. This approach avoids sternotomy and cardiopulmonary bypass, which significantly reduces recovery time. But there are real limitations. The procedure requires adequate landing zones. The right ventricular outflow tract must be large enough to accommodate the delivery sheath, which is roughly 22 French for the standard SAPIEN valve. Patients who have had multiple prior surgeries often have dense adhesions and distorted anatomy, making this approach risky or impossible. In those cases, surgical pulmonary valve replacement remains the only option. I encountered a specific problem a couple of years ago with a young woman who had repaired tetralogy of Fallot and was being evaluated for TPVR. The imaging showed that her outflow tract was too short to provide adequate fixation for the prosthetic valve. We considered a different approach, using a valved conduit, but the risk of coronary compression was too high given her anatomy. We ultimately recommended continued medical management with close surveillance. This decision was not popular with the patient, who wanted a definitive solution. But sometimes the best option is no option at all, and explaining that clearly is more important than offering a procedure that carries more risk than benefit.
Imaging Considerations
Echocardiography is the primary imaging modality for evaluating the pulmonary valve. Transthoracic echocardiography provides adequate views in most patients. The parasternal short-axis view at the base of the heart shows the valve in cross-section. The parasternal long-axis view aligned with the right ventricular outflow tract shows the valve in profile during the cardiac cycle. Cardiac MRI is the gold standard for quantifying right ventricular size and function in patients with pulmonary regurgitation. It provides accurate volumetric measurements without the geometric assumptions required by echocardiography. If you are making treatment decisions based on echocardiographic RV volumes alone, you are introducing uncertainty into your assessment. The typical workflow involves a comprehensive echocardiogram followed by cardiac MRI for pre-intervention planning. Cardiac computed tomography angiography has become increasingly important in this field. It provides detailed anatomical information about the right ventricular outflow tract, the pulmonary arteries, and the relationship to surrounding structures. This is essential for TPVR planning. The procedure requires careful measurement of the landing zone diameter and length. These measurements are made on contrast-enhanced CT images, typically during the pulmonary arterial phase. If you are using non-contrast scans or the wrong timing, your measurements will be inaccurate. This is not a minor issue. A mistake in landing zone measurement can result in valve malposition or embolization.
Practical Notes for Clinicians
When documenting pulmonary valve findings, be specific about which cusps are involved. The anterior cusp is the most clinically relevant in most pathologies, but naming it precisely helps surgeons understand what they are dealing with. A report that says "pulmonary valve thickening" without specifying the location is not useful for decision-making. Three words of specificity cost nothing and save hours of clarification later. The pulmonary valve is often described as having three cusps, but up to 15 percent of normal individuals have only two. This bicuspid variant is usually asymptomatic and does not require intervention. It is important to distinguish between a true bicuspid pulmonary valve and a trigeneric valve with fused leaflets. The distinction matters for prognosis and follow-up intensity. I have seen patients misdiagnosed with bicuspid pulmonary valve who actually had degenerative changes in a trileaflet valve. The management implications are different. If you are following a patient with isolated pulmonary regurgitation after tetralogy repair, the surveillance interval should be determined by the severity of regurgitation and right ventricular size. Mild regurgitation with normal RV dimensions can be followed every two to three years. Moderate or severe regurgitation with any sign of RV dilation requires annual imaging. This is a general guideline, not a rule. Each patient is different, and the imaging findings should drive the decision, not a calendar.
A Note on Limitations
Percutaneous pulmonary valve implantation is not a perfect solution. The bioprosthetic valves available today do not grow. This is a significant limitation in pediatric and adolescent patients. A 14-year-old who receives a TPVR may outgrow the valve and require surgical replacement within a decade. This is a reality that must be discussed with patients and families before the procedure. The alternative approaches, including homograft valves and Ross-type procedures, have their own limitations and are not necessarily better for every patient. Echocardiographic assessment of the pulmonary valve has inherent limitations. The valve is anterior in the chest, which makes it relatively accessible to ultrasound. But the right ventricular outflow tract is not always well-visualized, especially in patients with lung disease or obesity. In these cases, cardiac MRI or CT is necessary for adequate assessment. Relying solely on echocardiography in difficult patients introduces error. This is a practical constraint that every clinician working in this area encounters regularly. The pulmonary valve is a small structure with outsized clinical importance. It is easy to underestimate because it sits on the right side of the heart, away from the main clinical focus on left-sided pathology. But right ventricular function determines outcomes in numerous cardiac conditions. A dysfunctional pulmonary valve contributes to right ventricular failure, which is a leading cause of morbidity in adult congenital heart disease. Understanding the anatomy, function, and pathology of this valve is not optional for anyone working in cardiology or cardiothoracic surgery.
